Can carboplatin be omitted in neoadjuvant TCHP therapy in Her2+ breast cancer to avoid toxicity?  

In light of the KATHERINE data- does this change your practice?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution